Concepedia

Paula Soria‐Chacartegui

PS

Statistics

Publications

11

Citations

188

H-Index

10

Active since

2020

Affiliations

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas(Current)

Universidad Autónoma de Madrid

Hospital Universitario de La Princesa

Instituto de Salud Carlos III

Spanish Clinical Research Network

Paula Soria‐Chacartegui is an author at Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas specializing in pharmacogenetics, pharmacogenomics, and pharmacology.

ORCID

Publications per year

2020–2023

11

Publications

11

Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam

Pablo Zubiaur, Laura Figueiredo-Tor, Gonzalo Villapalos‐García et al. · Biomedicine & Pharmacotherapy · 2022 · 25 citations · Full text

, , +15

Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran

Pablo Zubiaur, Miriam Saiz‐Rodríguez, Dolores Ochoa et al. · Advances in Therapy · 2020 · 24 citations

, , +9

Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers

Pablo Zubiaur, Paula Soria‐Chacartegui, Dóra Koller et al. · Biomedicine & Pharmacotherapy · 2020 · 24 citations · Full text

, , +17

Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics

Pablo Zubiaur, Paula Fernández-Campos, Marcos Navares‐Gómez et al. · Pharmaceutics · 2021 · 20 citations · Full text

, , +17

Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers

Ana Casajús, Pablo Zubiaur, Marta Méndez et al. · Advances in Therapy · 2022 · 19 citations · Full text

, , +17

1–5 of 11